Testing effectiveness (Phase 2)Study completedNCT00687765
What this trial is testing
Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma
Who this might be right for
Glioblastoma
Sanofi 126